The U-M Samuel and Jean Frankel Cardiovascular Center is on the forefront of innovative, advanced efforts to combat the magnitude of cardiovascular disease.
Great talk by Andrew Huang and Craig Brown at Midwestern Vascular Surgery! Important to achieve long term medical adherence yo improve dissection outcomes. @umichCVC@MWVSSociety@UMichSurgery
Congratulations to Dr. @venkmurthy on his appointment to the U.S. Preventive Services Task Force (USPSTF).
Murthy, a cardiologist and health innovation researcher at the Frankel Cardiovascular Center, is one of eight new members selected to serve on the task force.
“I am honored by the opportunity to serve the nation by applying gold-standard science to improve the health of all Americans,” Murthy said.
Click this link to learn more: michmed.org/XGAK2
Honored to serve the American people on the US Preventive Services Task Force
I am looking forward to advising @HHSGov on preventive health measures
🇺🇸🇺🇸🇺🇸
uspreventiveservicestaskforc…
Excited to share the Davis Lab is now NIH R01-funded! We'll be investigating epigenetic regulation of macrophage inflammation in abdominal aortic aneurysm development. Grateful for this opportunity to dig deeper into vascular inflammation biology. 🧬🔬
medresearch.umich.edu/labs-d…
Do you have questions about DVTs or PEs? Vascular Surgery is live. @thevasculardr is talking with @GBarnesMD@umichCVC. Call 877-698-3627 or email docs@siriusxm.com with your questions. Stream it here: sxm.app.link/DoctorRadio
Congrats to Garbincius Lab undergraduate Anika Patel for presenting her research at the Frankel Cardiovascular Center SURF Symposium this afternoon! Special thanks to @umichCVC and @AHA_Research for supporting this wonderful program!
Congratulations to Anand Singh, Ph.D., on receiving a $2.2 million R01 grant from the @NIH to investigate ways to reduce the cardiotoxic side effects associated with osimertinib, the only approved therapy for EGFR T790M-positive non-small cell lung cancer.
ALT Congratulations message for Anand P. Singh Ph.D., Research Investigator. Mentions a National Institutes of Health grant for research on cancer therapy-induced cardiotoxic complications. Includes logos for the University of Michigan Health and the Samuel and Jean Frankel Cardiovascular Center.
Up to 5% of patients on the drug experience serious cardiac events. Singh’s team will investigate the mechanisms that cause cardiotoxicity after osimertinib treatment, as well as possible therapeutic targets to prevent that damage.
Learn more: michmed.org/ZGw9A
If you've been diagnosed with aortic valve disease, you have more treatment options than ever before.
In a recent livestream, our experts discussed TAVR + SAVR, how they help patients choose the right treatment, & how the latest advances in valve technology are improving care.
Congrats to @venkmurthy & Sascha Goonewardena for receiving funding from @wellcomeleap's VISIBLE program to develop inexpensive, scalable diagnostics for coronary microvascular dysfunction. They'll also study the distinct mechanisms which promote coronary artery disease in women.
ALT This image features a promotional banner from the Frankel Cardiovascular Center at the University of Michigan Health. It highlights Venkatesh Murthy, M.D., Ph.D., and Sascha Goonewardena, M.D., expert faculty in heart disease research. Both are shown in professional attire along with their titles and roles. The background emphasizes the theme of advancing research in women's heart disease.
“We are proud to participate in this initiative to address the leading cause of death among women,” Murthy said. “This initiative builds on the team strengths at Michigan and will hopefully allow us to bring those same strengths to the world.”
Learn more: michmed.org/XGwGv